History, habits and goals
The doctor reviews personal and family history, lifestyle, previous tests and questions about the test.
Accompanied genetic evaluation
Genetics interpreted within your health history.
Longevo Premium offers the same genetic content as Longevo, plus pre-test medical consultation, post-test consultation and annual clinical re-evaluation of data for four consecutive years.
- Genetic content
- Same as Longevo
- Queries
- Pre and post-test
- Reassessments
- Annual for four years
Longitudinal monitoring
The examination begins before sample collection.
The pre-test consultation defines the relevant questions. After the analysis, the post-test consultation organizes what the result means for you. Over the next four years, an annual clinical reassessment revisits the data in light of new evidence and your health monitoring.
The same genetic content
The sample is collected with a mouth swab and goes through the same genetic analysis, specialized curation and preventive scope offered by Longevo.
Result in context, year after year
The post-test consultation explains findings, limits and next steps. The data then receives annual clinical reassessment for four consecutive years.
Same content as Longevo
More than 100 conditions evaluated.
Longevo Premium fully maintains the genetic analysis of Longevo: 155 genes, selected polygenic scores and pharmacogenomics. The difference is in the clinical journey before, after and over the following four years.
01
Hereditary cancer
Breast and ovarian, colorectal, prostate, endocrine tumors, melanoma and other predisposing syndromes.
02
Cardiovascular health
Cardiomyopathies, arrhythmias, aortic diseases, hereditary cholesterol and polygenic risk of heart attack.
03
Neurology and metabolism
Neurodegenerative, neuromuscular, metabolic, endocrine conditions and changes in iron metabolism.
04
Pharmacogenomics
Information on the response and metabolism of selected medications, including in mental health.
Medical follow-up
Clinical experience to interpret what matters.
Monitoring is carried out by Dr. João Bosco de Oliveira Filho, founder of NeoGenomica and a doctor with more than 20 years of experience in clinical genetics.
- Before the test
- Defining objectives and collecting clinical information.
- After the report
- Post-test consultation and annual clinical re-evaluation of data for four consecutive years.
Post-report follow-up
Science evolves. The interpretation of a variant may also evolve.
All NeoGenomica tests include Infinity VUS for variants of uncertain significance that are reported.
Your result monitored over time
A variant of uncertain significance, or VUS, is a finding for which the available evidence does not yet allow us to conclude whether it is related to the disease. Infinity VUS monitors classification updates even after the report is issued.
-
01 · Monitor
Periodically compares reported VUS with new evidence and classifications.
-
02 · Review
A material change is forwarded for expert review before any communication.
-
03 · Update
When the reclassification is confirmed and applicable to the case, the responsible team is notified and the report can be updated.
Accompanied journey
From assessment to monitoring.
An organized journey to link genetic data, history and prevention.
-
01
Scheduling
The team confirms the service and guides the preparation for the evaluation.
-
02
Pre-test consultation
The doctor reviews the history, objectives and questions before sample collection.
-
03
Sample collection
The buccal swab is collected and sent to the laboratory with traceability.
-
04
Genetic analysis
The DNA goes through the same genetic content and the same curation as Longevo.
-
05
Return and follow-up
The report is contextualized in the post-test consultation and the data receives annual clinical reevaluation for four consecutive years.
Clinical feedback
Clarity about findings and limits.
The report brings together the results by clinical area. At the return visit, each finding is related to the history and follow-up recommendations.
- Summary of main findings.
- Analysis by health category.
- Points for prevention, tracking and referral.
Frequently asked questions
Before scheduling.
What is the difference between Longevo and Longevo Premium?+
The genetic content is the same. Longevo Premium adds pre-test consultation, post-test consultation and annual clinical re-evaluation of data for four consecutive years.
How do four-year revaluations work?+
Once a year, for four consecutive years, data is clinically reassessed to consider new relevant evidence and the updated health context. Reevaluation does not replace consultations, routine tests or care monitoring.
Do I need a medical request?+
No. The initial assessment itself organizes the indication, objectives and information necessary for the test.
How are consultations carried out?+
The team informs you of the modality and availability when scheduling. The first consultation takes place before sample collection and the return after the report is released.
Does the result automatically change medications or screenings?+
No. The report generates information for clinical discussion. Changes in treatment, medication or screening depend on individual assessment.
Is the test covered by health insurance?+
The service is private. The team can provide documentation to request reimbursement when the plan contract allows.
When will the result be ready?+
The deadline currently stated is up to 20 calendar days after receipt and acceptance of the sample. Return consultation is organized after release.
Clinical follow-up
Start with the conversation, not the report.
Schedule a pre-test consultation and understand how Longevo Premium can track your data for four consecutive years.
Catalog information
Technical data of Longevo Premium
The same content as Longevo, with pre- and post-test consultations and annual clinical reassessment for four years.
- Applications
- Hereditary cancer, Personalized prevention, Cardiovascular risk, Pharmacogenomics
- Accepted samples
- peripheral blood, Mouth swab (preferred), DNA extraído
- Estimated deadline
- 20 calendar days, contados após sample acceptance.
- Methodology
- Genetic content and curation of Longevo, integrated with longitudinal medical monitoring.
- Analytical scope
- 155 genes, selected polygenic scores and pharmacogenomics; pre- and post-examination consultations and an annual clinical reassessment for four years.
- Medical request
- Not mandatory
Requirements
Does not require a medical request; the initial assessment organizes indication, objectives and necessary information. Home sample collection uses a mouth swab.
Limitations
Findings and scores must be interpreted in conjunction with history, habits, tests and goals of care.
